Erythropoietin

Area of Science:

• Sports Science
• Biochemistry
• Anti-Doping Research

Background:

• Erythropoietin (Epo) regulates red blood cell production, impacting aerobic capacity.
• Performance-enhancing drugs mimicking Epo are used by athletes to increase hemoglobin mass.
• Detecting these substances is crucial for fair competition.

Purpose of the Study:

• To review the regulation of erythropoiesis.
• To discuss methods for manipulating erythropoiesis.
• To highlight challenges and strategies in anti-doping efforts.

Main Methods:

• Review of scientific literature on erythropoiesis regulation and Epo.
• Analysis of detection methods for recombinant human Epo (rhEpo) and analogues.
• Discussion of emerging doping agents and detection challenges.
• Explanation of the Athlete Biological Passport (ABP) system.

Main Results:

• Various forms of Epo and related drugs can be misused to enhance athletic performance.
• Detection of synthetic Epo is possible due to differing glycan structures.
• New agents like Epo mimetics and HIF stabilizers complicate anti-doping efforts.
• The ABP provides continuous monitoring of athlete biological parameters.

Conclusions:

• Anti-doping strategies must evolve to counter new erythropoiesis-stimulating agents.
• The ABP is a key tool for detecting non-physiological changes indicative of blood doping.
• Continuous monitoring of hemoglobin and reticulocyte parameters is vital for integrity in sports.